Published in Pharma Law Weekly, August 16th, 2005
Reporting in Transplantation, lead author Dani Zander, MD, of the University of Texas Medical School at Houston, and colleagues at the University of Florida College of Medicine found that less than 1% of a certain type of reparative lung stem cell originated in the bone marrow of the transplant recipient.
"It's possible in the future that circulating stem cells could be augmented to play a greater role in lung repair - and people are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly